US Stock MarketDetailed Quotes

CNTX Context Therapeutics

Watchlist
  • 0.6551
  • -0.0814-11.05%
Close Mar 28 16:00 ET
  • 0.6551
  • 0.00000.00%
Post 20:01 ET
58.77MMarket Cap-1.42P/E (TTM)

Context Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.84%-14.56M
32.11%-4.91M
44.14%-1.93M
27.54%-3.36M
23.88%-4.36M
-55.34%-21.05M
-83.91%-7.23M
-15.59%-3.46M
-65.09%-4.63M
-49.95%-5.73M
Net income from continuing operations
-11.52%-26.73M
50.62%-3.34M
-197.21%-17.46M
55.01%-2.25M
41.86%-3.67M
-61.53%-23.96M
-90.34%-6.77M
-52.42%-5.87M
-25.71%-5.01M
-83.47%-6.31M
Operating gains losses
-19.52%41.82K
--25.32K
----
----
----
-33.82%51.97K
--0
-65.01%7.52K
5.44%22.37K
57.44%22.08K
Depreciation and amortization
-9.66%10.88K
14.25%2.93K
-9.00%2.81K
-19.60%2.57K
-19.57%2.57K
29.95%12.04K
-19.60%2.57K
-3.26%3.09K
10.86%3.19K
--3.19K
Other non cash items
--14.75M
--0
----
----
----
----
----
----
----
----
Change In working capital
-295.75%-3.48M
-154.77%-1.82M
-74.67%544.25K
-1,862.27%-1.26M
-444.11%-935.4K
739.84%1.78M
-11.60%-715.91K
284.30%2.15M
-82.80%71.55K
144.50%271.83K
-Change in prepaid assets
-346.27%-1.87M
-623.01%-2.2M
-108.42%-107.63K
53.35%-212.14K
170.55%647.9K
203.09%758.83K
-294.95%-303.85K
236.90%1.28M
-1.16%-454.72K
-51.23%239.48K
-Change in payables and accrued expense
-250.68%-1.57M
196.58%397.98K
-21.79%668.16K
-291.45%-1.05M
-3,317.81%-1.58M
83.39%1.04M
47.23%-412.05K
-42.54%854.29K
-41.21%547.78K
104.59%49.2K
-Change in other current assets
--0
--0
--0
--0
--0
200.00%32.75K
--0
-15.60%24K
105.00%2.19K
127.34%6.56K
-Change in other current liabilities
25.09%-41.26K
---24.98K
-104.32%-16.28K
--0
--0
26.96%-55.08K
--0
65.11%-7.97K
-5.12%-23.7K
-238.72%-23.41K
Cash from discontinued investing activities
Operating cash flow
30.84%-14.56M
32.11%-4.91M
44.14%-1.93M
27.54%-3.36M
23.88%-4.36M
-55.34%-21.05M
-83.91%-7.23M
-15.59%-3.46M
-65.09%-4.63M
-49.95%-5.73M
Investing cash flow
Cash flow from continuing investing activities
-14.76M
0
0
0
Net PPE purchase and sale
---7.32K
--0
----
----
----
--0
--0
----
----
----
Net intangibles purchase and sale
---14.75M
--0
----
----
----
--0
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
---14.76M
--0
----
----
----
--0
--0
----
----
----
Financing cash flow
Cash flow from continuing financing activities
109.29M
14.54M
-44.63K
0
0
0
Net common stock issuance
--109.29M
--14.54M
---44.63K
----
----
--0
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--109.29M
--14.54M
---44.63K
----
----
--0
--0
--0
----
----
Net cash flow
Beginning cash position
-59.29%14.45M
291.21%84.8M
303.92%101.54M
-66.11%10.09M
-59.29%14.45M
-28.56%35.5M
-45.02%21.68M
-41.43%25.14M
-34.90%29.77M
-28.56%35.5M
Current changes in cash
480.00%79.98M
233.22%9.63M
-383.55%-16.74M
2,074.64%91.45M
23.88%-4.36M
-48.35%-21.05M
-83.91%-7.23M
0.95%-3.46M
-64.98%-4.63M
-44.75%-5.73M
End cash Position
553.50%94.43M
553.50%94.43M
291.21%84.8M
303.92%101.54M
-66.11%10.09M
-59.29%14.45M
-59.29%14.45M
-45.02%21.68M
-41.43%25.14M
-34.90%29.77M
Free cash flow
-39.27%-29.31M
32.11%-4.91M
-382.27%-16.69M
27.54%-3.36M
23.88%-4.36M
-49.42%-21.05M
-83.91%-7.23M
0.95%-3.46M
-64.98%-4.63M
-48.59%-5.73M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.84%-14.56M32.11%-4.91M44.14%-1.93M27.54%-3.36M23.88%-4.36M-55.34%-21.05M-83.91%-7.23M-15.59%-3.46M-65.09%-4.63M-49.95%-5.73M
Net income from continuing operations -11.52%-26.73M50.62%-3.34M-197.21%-17.46M55.01%-2.25M41.86%-3.67M-61.53%-23.96M-90.34%-6.77M-52.42%-5.87M-25.71%-5.01M-83.47%-6.31M
Operating gains losses -19.52%41.82K--25.32K-------------33.82%51.97K--0-65.01%7.52K5.44%22.37K57.44%22.08K
Depreciation and amortization -9.66%10.88K14.25%2.93K-9.00%2.81K-19.60%2.57K-19.57%2.57K29.95%12.04K-19.60%2.57K-3.26%3.09K10.86%3.19K--3.19K
Other non cash items --14.75M--0--------------------------------
Change In working capital -295.75%-3.48M-154.77%-1.82M-74.67%544.25K-1,862.27%-1.26M-444.11%-935.4K739.84%1.78M-11.60%-715.91K284.30%2.15M-82.80%71.55K144.50%271.83K
-Change in prepaid assets -346.27%-1.87M-623.01%-2.2M-108.42%-107.63K53.35%-212.14K170.55%647.9K203.09%758.83K-294.95%-303.85K236.90%1.28M-1.16%-454.72K-51.23%239.48K
-Change in payables and accrued expense -250.68%-1.57M196.58%397.98K-21.79%668.16K-291.45%-1.05M-3,317.81%-1.58M83.39%1.04M47.23%-412.05K-42.54%854.29K-41.21%547.78K104.59%49.2K
-Change in other current assets --0--0--0--0--0200.00%32.75K--0-15.60%24K105.00%2.19K127.34%6.56K
-Change in other current liabilities 25.09%-41.26K---24.98K-104.32%-16.28K--0--026.96%-55.08K--065.11%-7.97K-5.12%-23.7K-238.72%-23.41K
Cash from discontinued investing activities
Operating cash flow 30.84%-14.56M32.11%-4.91M44.14%-1.93M27.54%-3.36M23.88%-4.36M-55.34%-21.05M-83.91%-7.23M-15.59%-3.46M-65.09%-4.63M-49.95%-5.73M
Investing cash flow
Cash flow from continuing investing activities -14.76M000
Net PPE purchase and sale ---7.32K--0--------------0--0------------
Net intangibles purchase and sale ---14.75M--0--------------0--0------------
Cash from discontinued investing activities
Investing cash flow ---14.76M--0--------------0--0------------
Financing cash flow
Cash flow from continuing financing activities 109.29M14.54M-44.63K000
Net common stock issuance --109.29M--14.54M---44.63K----------0--0--0--------
Cash from discontinued financing activities
Financing cash flow --109.29M--14.54M---44.63K----------0--0--0--------
Net cash flow
Beginning cash position -59.29%14.45M291.21%84.8M303.92%101.54M-66.11%10.09M-59.29%14.45M-28.56%35.5M-45.02%21.68M-41.43%25.14M-34.90%29.77M-28.56%35.5M
Current changes in cash 480.00%79.98M233.22%9.63M-383.55%-16.74M2,074.64%91.45M23.88%-4.36M-48.35%-21.05M-83.91%-7.23M0.95%-3.46M-64.98%-4.63M-44.75%-5.73M
End cash Position 553.50%94.43M553.50%94.43M291.21%84.8M303.92%101.54M-66.11%10.09M-59.29%14.45M-59.29%14.45M-45.02%21.68M-41.43%25.14M-34.90%29.77M
Free cash flow -39.27%-29.31M32.11%-4.91M-382.27%-16.69M27.54%-3.36M23.88%-4.36M-49.42%-21.05M-83.91%-7.23M0.95%-3.46M-64.98%-4.63M-48.59%-5.73M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More